The innovative technology of IMPACT permits the preparation of a broad variety of autologous blood derivatives like various PRP-variants, ACS or BMC. Since not all PRP is the same, the IMPACT user can decide whether there shall be leukocytes present in the PRP or not. Also, the concentration of platelets can be chosen depending on the therapeutic objective. And that, by means of a simple, fully automated reparation process. Scientifically tested IMPACT programs with specific parameters are recommended to produce different blood derivatives with specific compositions and thus, characteristics . In addition, the system also permits the physician to define and store own program variants.
Modern regenerative medicine to personalize treatment options to each patient‘s needs.
The IMPACT platform centrifuges and separates the requested blood fractions fully automated and in a closed system. The integral optical sensor separates reliably and precisely. The syringe with the patient’s blood is laid into the special rotor of the platform, and after the program has been completed, the requested autologous blood product is removed and “ready-to-use”
• Standardized preparation protocols for the different autologous blood derivatives
• Scientifically proven, reproducible compositions of the different IMPACT programs/ blood derivatives – despite all intra-individual
differences in the blood.
• High cell yield and high therapeutic safety
Blood collection: 12 ml of whole blood
Connect the syringe filled with whole blood to the empty IMPACT syringe
using the tube included in
the IMPACT set
Place the connected syringes (so-called tandem) into the rotor. If desired, place a second tandem
Select your desired program, the blood sample is being processed accordingly and the autologous blood derivative is separated automatically
Once program completed, remove the syringes. Detach the syringe with the autologous ready-to-use blood product
Injection to the defect site
Dimensions (H × W × D): 456 x 555 x 707 mm
Capacity: 2 x 12 ml
Max. RPM: 2.800
Max. RCF: 940
Intuitive user-friendly touch display for easy operation
The IMPACT system can be used to prepare a number of different autologous cell therapies at the push of a button. The selection is
made depending on the respective therapeutic objective. Single-use sets are available for different therapeutic applications:
IMPACT PRP – Platelet Rich Plasma
Without anti-coagulant for the preparation of a “single-spin”, slightly concentrated PRP
IMPACT APC – Autologous Platelet Concentrate
With anti-coagulant for the preparation of a concentrated PRP
IMPACT ACS – Autologous Conditioned Serum
For the preparation of an autologous conditioned serum rich in anti-inflammatory cytokines
IMPACT BMC – Bone Marrow Concentrate
For the production of bone marrow aspirate concentrate
